D. Mcgonagle
Impact in
- Rheumatology top 5%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 10
- Spondyloarthritis Studies and Treatments 8
- Rheumatoid Arthritis Research and Therapies 7
- Systemic Lupus Erythematosus Research 2
- Musculoskeletal synovial abnormalities and treatments 2
-
- Psoriasis: Treatment and Pathogenesis 4
- IL-33, ST2, and ILC Pathways 1
- Co-authors
- M. Bollow (1 shared paper)C Althoff (1 shared paper)Kay‐Geert Hermann (1 shared paper)Iris Eshed (1 shared paper)Ai Lyn Tan (1 shared paper)Patrick Asbach (1 shared paper)Michael McDermott (1 shared paper)Laura Dickie (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (8 papers)Clinical and Experimental Rheumatology (1 paper)Lara D. Veeken (1 paper)Imaging (2 papers)PubMed (1 paper)
- Partner nations
- United KingdomCanadaAustralia
In The Last Decade
D. Mcgonagle
11 papers receiving 275 citations
Peers
Comparison fields: 5 of 43
- Rheumatology 224
- Hematology 103
- Orthopedics and Sports Medicine 75
- Immunology 112
- Dermatology 28
Countries citing papers authored by D. Mcgonagle
This map shows the geographic impact of D. Mcgonagle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Mcgonagle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Mcgonagle more than expected).
Fields of papers citing papers by D. Mcgonagle
This network shows the impact of papers produced by D. Mcgonagle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Mcgonagle. The network helps show where D. Mcgonagle may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Mcgonagle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 140 | |
| 2 | 2011 | 68 | |
| 3 | 2019 | 37 | |
| 4 | A randomized controlled trial of infliximab shows clinical and MRI efficacy in HLA B27 positive very early ankylosing spondylitis | 2008 | 11 |
| 5 | 2021 | 8 | |
| 6 | 2007 | 6 | |
| 7 | 2003 | 6 | |
| 8 | 2012 | 3 | |
| 9 | 2022 | 1 | |
| 10 | 2016 | 1 | |
| 11 | 2016 | 1 | |
| 12 | 2024 | 0 | |
| 13 | 2024 | 0 |
About D. Mcgonagle
D. Mcgonagle is a scholar working on Rheumatology, Immunology, Hematology, Orthopedics and Sports Medicine and Surgery, having authored 13 papers that have together received 282 indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (8 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Psoriasis: Treatment and Pathogenesis (4 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Systemic Lupus Erythematosus Research (2 papers), Musculoskeletal synovial abnormalities and treatments (2 papers), Bone and Joint Diseases (2 papers) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Rheumatology (224 citations), Hematology (103 citations), Orthopedics and Sports Medicine (75 citations), Immunology (112 citations) and Dermatology (28 citations). D. Mcgonagle has collaborated with scholars based in United Kingdom, Canada and Australia. Frequent co-authors include M. Bollow, C Althoff, Kay‐Geert Hermann, Iris Eshed, Ai Lyn Tan, Patrick Asbach, Michael McDermott, Laura Dickie, Sibel Zehra Aydın and Zoe Ash. Their work appears in journals such as Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Lara D. Veeken, Imaging and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.